Banner

Recombinant DNA Technology Global Market Report 2023 – By Product Type (Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell and Gene Therapy, Gene Editing), By Component Type (Expression System, Cloning Vector), By Application Type (Food And Agriculture, Health And Disease, Environment, Other Application Types), By End-Use Type (Biotechnology And Pharmaceutical Companies, Academic And Government Research Institutes, Other End-Use Types) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 200 | Published : January 2023 | SKU CODE : | Delivery Time: 2-3 business days | Format :


Recombinant DNA technology refers to fusing DNA molecules from other organisms and inserting those DNA molecules into a host organism to build a new genetic combinations useful for science, medicine, agriculture, and industry. The recombinant DNA technology is used to address health issues by creating new medications and vaccines.

The main product type of recombinant DNA technology include recombinant protein drugs, vaccines, genetically modified crops, expression systems, cell and gene therapy and gene editing. The recombinant protein drugs are used in the biochemical analysis as well as medical diagnostic reagents in human healthcare, such as antibodies, medicines, or vaccines. Recombinant protein drugs are referred to as highly potent medicines that develop faster than small molecules and are safe from off-target negative effects. The component type include expression system and cloning vector. The recombinant DNA technology is applied in food and agriculture, health and disease, environment and other applications and used in biotechnology and pharmaceutical companies, academic and government research institutes and other end-use industries.

The recombinant DNA technology market research report is one of a series of new reports from The Business Research Company that provides recombinant DNA technology market statistics, including recombinant DNA technology industry global market size, regional shares, competitors with an recombinant DNA technology market share, detailed recombinant DNA technology market segments, market trends and opportunities, and any further data you may need to thrive in the recombinant DNA technology industry. This recombinant DNA technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The global recombinant DNA technology market size is expected to grow from $754.97 billion in 2022 to $811.89 billion in 2023 at a compound annual growth rate (CAGR) of 7.54%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The recombinant DNA technology market size is expected to reach $1,069.51 billion in 2027 at a CAGR of 7.13%.

The increasing number of chronic diseases is expected to propel the growth of the recombinant DNA technology market. Chronic diseases, which are defined as ailments that last for a year or longer, necessitate continuing medical care, restrict everyday activities, or both. Recombinant DNA technology has improved healthcare by creating biopharmaceuticals proteins used in pharmaceuticals and by replacing defective genes with healthy ones through gene therapy, aiming to cure illness. For instance, in April 2021, according to a report shared by WHO, a Switzerland-based specialized agency of the United Nations responsible for international public health, noncommunicable diseases (NCDs) accounted for 41 million annual deaths, or 71% of all deaths worldwide. Between the ages of 30 and 69, more than 15 million people per year die from an NCD; 85% of these premature deaths take place in low- and middle-income nations. Therefore, the increase in chronic diseases is driving the recombinant DNA technology market.

Technological advancement is a key trend in the recombinant DNA technology market. Major companies operating in the recombinant DNA technology market are focused on innovative technologies to sustain their position in the market. For instance, in October 2021, Thermo Fisher Scientific, a US-based supplier of scientific instrumentation, reagents and consumables, and software services, introduced the Applied Biosystem QuantStudio Absolute Q-Digital PCR System, the first fully integrated digital PCR (dPCR) equipment made to deliver extremely precise and reliable findings in genetic analysis and research in less than 90 minutes. The QuantStudio Absolute Q System uses microfluidic array technology and streamlined processes instead of the complicated, multi-instrument workflows necessary for standard dPCR, which is intended to increase data accuracy and consistency. The QuantStudio Absolute Q solution is a quick and easy workflow that provides high-quality data with the least amount of manual labour. It combines the data collection, heat cycling, and digitization processes required for dPCR into a single device.

In January 2022, Thermo Fisher Scientific, a US-based scientific instrumentation supplier, reagents, consumables, and software services, acquired PeproTech for $1.85 billion. The acquisition complements Thermo Fisher's cell culture media products with PeproTech's recombinant proteins portfolio, which is expected to allow Thermo Fisher to give customers significant advantages through an integrated offering. PeproTech, Inc. is a US-based developer and manufacturer of bioscience reagents known as recombinant proteins.

Major players in the recombinant DNA technology market are Profacgen, Amgen Inc., Novartis AG, GenScript, Pfizer Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi, Merck & Co. Inc., Biogen, GlaxoSmithKline PLC., New England Biolabs, Monsanto Company, Thermo Fisher Scientific, Inc., and F. Hoffmann-La Roche Ltd.

North America was the largest region in the recombinant DNA technology market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the recombinant DNA technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the Recombinant DNA Technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The recombinant DNA technology market includes revenues earned by entities by expression systems including mammalian, bacteria, yeast, and baculovirus / insect. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The global recombinant DNA technology market is segmented -

1) By Product Type: Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell and Gene Therapy, Gene Editing

2) By Component Type: Expression System, Cloning Vector

3) By Application Type: Food And Agriculture, Health And Disease, Environment, Other Application Types

4) By End-Use Type: Biotechnology And Pharmaceutical Companies, Academic And Government Research Institutes, Other End-Use Types

    Table Of Contents

    1. Executive Summary

    2. Recombinant DNA Technology Market Characteristics

    3. Recombinant DNA Technology Market Trends And Strategies

    4. Recombinant DNA Technology Market - Macro Economic Scenario

    4.1. COVID-19 Impact On Recombinant DNA Technology Market

    4.2. Ukraine-Russia War Impact On Recombinant DNA Technology Market

    4.3. Impact Of High Inflation On Recombinant DNA Technology Market

    5. Recombinant DNA Technology Market Size And Growth

    5.1. Global Recombinant DNA Technology Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Recombinant DNA Technology Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Recombinant DNA Technology Market Segmentation

    6.1. Global Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Recombinant Protein Drugs

    Vaccines

    Genetically Modified Crops

    Expression Systems

    Cell And Gene Therapy

    Gene Editing

    6.2. Global Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Expression System

    Cloning Vector

    6.3. Global Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Food And Agriculture

    Health And Disease

    Environment

    Other Application Types

    6.4. Global Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Biotechnology And Pharmaceutical Companies

    Academic And Government Research Institutes

    Other End-Use Types

    7. Recombinant DNA Technology Market Regional And Country Analysis

    7.1. Global Recombinant DNA Technology Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Recombinant DNA Technology Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Recombinant DNA Technology Market

    8.1. Asia-Pacific Recombinant DNA Technology Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Recombinant DNA Technology Market

    9.1. China Recombinant DNA Technology Market Overview

    9.2. China Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Recombinant DNA Technology Market

    10.1. India Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Recombinant DNA Technology Market

    11.1. Japan Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Recombinant DNA Technology Market

    12.1. Australia Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Recombinant DNA Technology Market

    13.1. Indonesia Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Recombinant DNA Technology Market

    14.1. South Korea Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Recombinant DNA Technology Market

    15.1. Western Europe Recombinant DNA Technology Market Overview

    15.2. Western Europe Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Recombinant DNA Technology Market

    16.1. UK Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Recombinant DNA Technology Market

    17.1. Germany Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Recombinant DNA Technology Market

    18.4. France Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Recombinant DNA Technology Market

    19.1. Eastern Europe Recombinant DNA Technology Market Overview

    19.2. Eastern Europe Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Recombinant DNA Technology Market

    20.1. Russia Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Recombinant DNA Technology Market

    21.1. North America Recombinant DNA Technology Market Overview

    21.2. North America Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Recombinant DNA Technology Market

    22.1. USA Recombinant DNA Technology Market Overview

    22.2. USA Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Recombinant DNA Technology Market

    23.1. South America Recombinant DNA Technology Market Overview

    23.2. South America Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Recombinant DNA Technology Market

    24.1. Brazil Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Recombinant DNA Technology Market

    25.1. Middle East Recombinant DNA Technology Market Overview

    25.2. Middle East Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Recombinant DNA Technology Market

    26.1. Africa Recombinant DNA Technology Market Overview

    26.2. Africa Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Recombinant DNA Technology Market Competitive Landscape And Company Profiles

    27.1. Recombinant DNA Technology Market Competitive Landscape

    27.2. Recombinant DNA Technology Market Company Profiles

    27.2.1. Profacgen

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Amgen Inc

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Novartis AG

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. GenScript

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Pfizer Inc

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Recombinant DNA Technology Market

    29. Recombinant DNA Technology Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Recombinant DNA Technology Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Global Recombinant DNA Technology Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: Asia-Pacific, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: China, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: India, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Japan, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Australia, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: Indonesia, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: South Korea, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: Western Europe, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: UK, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: Germany, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: France, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Eastern Europe, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: Russia, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: North America, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: USA, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: South America, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Brazil, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Middle East, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Africa, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 47: Profacgen Financial Performance
  • Table 48: Amgen Inc Financial Performance
  • Table 49: Novartis AG Financial Performance
  • Table 50: GenScript Financial Performance
  • Table 51: Pfizer Inc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Recombinant DNA Technology Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Global Recombinant DNA Technology Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: Asia-Pacific, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: China, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: India, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Japan, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Australia, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: Indonesia, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: South Korea, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: Western Europe, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: UK, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: Germany, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: France, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Eastern Europe, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: Russia, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: North America, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: USA, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: South America, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Brazil, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Middle East, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Africa, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 47: Profacgen Financial Performance
  • Figure 48: Amgen Inc Financial Performance
  • Figure 49: Novartis AG Financial Performance
  • Figure 50: GenScript Financial Performance
  • Figure 51: Pfizer Inc Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report